CoreAge Rx vs Kongo
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Kongo head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 69 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Kongo a bad call — it's best for readers comparing a shorter monthly option with a first-quarter promotion who can confirm renewal and cancellation terms. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Kongo |
|---|---|---|
| Brief Score | 94/100 (A) | 69/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $109/mo monthly option Regular three-month plan: $285. Eligible first-quarter offer: $190, returning to $285 for the next three-month term. Full price details$109/month compounded semaglutide; regular 3-month plan $285 total; limited new-patient code offer $190 for first 3 months |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $209/mo monthly option Regular three-month plan: $387. Eligible first-quarter offer: $258, returning to $387 for the next three-month term. Full price details$209/month compounded tirzepatide; regular 3-month plan $387 total; limited new-patient code offer $258 for first 3 months |
| Coverage | US only; restrictions by state, confirmed at intake | Service limited to supported states; confirm individual clinician and pharmacy eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Kongo: Monthly options are $109 semaglutide/$209 tirzepatide. First-quarter code offers $190/$258 revert to regular $285/$387 quarterly; eligibility conditions apply.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.